IRIS
ORDITURA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.272
NA - Nord America 4.834
AS - Asia 4.231
SA - Sud America 784
AF - Africa 72
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 22.213
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.692
US - Stati Uniti d'America 4.707
SG - Singapore 1.480
IE - Irlanda 1.379
CN - Cina 968
HK - Hong Kong 752
BR - Brasile 669
IT - Italia 656
UA - Ucraina 633
GB - Regno Unito 490
DE - Germania 487
FR - Francia 334
KR - Corea 333
VN - Vietnam 252
FI - Finlandia 188
SE - Svezia 146
GR - Grecia 119
IN - India 113
TR - Turchia 97
CA - Canada 81
JP - Giappone 76
AR - Argentina 39
PL - Polonia 35
ID - Indonesia 30
BD - Bangladesh 29
MX - Messico 26
AT - Austria 24
IQ - Iraq 21
EC - Ecuador 20
NL - Olanda 18
BE - Belgio 16
ZA - Sudafrica 16
CO - Colombia 13
MA - Marocco 13
SC - Seychelles 13
CZ - Repubblica Ceca 11
ES - Italia 11
VE - Venezuela 11
PK - Pakistan 10
CL - Cile 9
PE - Perù 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
AL - Albania 6
EG - Egitto 6
EU - Europa 6
IR - Iran 6
KE - Kenya 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
NP - Nepal 5
AU - Australia 4
BO - Bolivia 4
HN - Honduras 4
JM - Giamaica 4
JO - Giordania 4
LB - Libano 4
LT - Lituania 4
CH - Svizzera 3
DK - Danimarca 3
ET - Etiopia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
MY - Malesia 3
UY - Uruguay 3
AZ - Azerbaigian 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
HU - Ungheria 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NO - Norvegia 1
QA - Qatar 1
Totale 22.211
Salva come PNG Salva come JPEG
Città #
Moscow 2.743
Dublin 1.368
Jacksonville 934
Hong Kong 751
Santa Clara 722
Chandler 643
Singapore 584
Seoul 310
Princeton 188
Medford 171
New York 131
Caserta 129
Bremen 121
Hefei 119
Roxbury 118
Ann Arbor 107
Beijing 107
Boardman 103
Ashburn 100
San Mateo 94
Bengaluru 87
Naples 86
Munich 85
Ho Chi Minh City 79
Wilmington 75
São Paulo 59
Woodbridge 59
The Dalles 53
Dallas 52
Elora 52
Hanoi 49
Nanjing 49
Des Moines 45
Los Angeles 43
Dong Ket 36
Napoli 36
Cambridge 34
Nuremberg 33
Jinan 32
Kraków 29
Rio de Janeiro 23
Helsinki 21
Milan 21
Houston 20
Mountain View 20
Turku 18
Tianjin 17
Brussels 15
Norwalk 15
Shanghai 15
Aiello Del Sabato 14
Changsha 14
Curitiba 14
Nanchang 14
Shenyang 14
Belo Horizonte 13
Hangzhou 13
Vienna 13
Guangzhou 12
Porto Alegre 12
Brasília 11
Haiphong 11
Ottawa 11
Zhengzhou 11
Auburn Hills 10
Aversa 10
Brno 10
Campinas 10
Taizhou 10
Guarulhos 9
Jakarta 9
Johannesburg 9
Toronto 9
Columbus 8
Da Nang 8
Dhaka 8
Düsseldorf 8
Rome 8
Amsterdam 7
Baghdad 7
Ercolano 7
Falkenstein 7
Fortaleza 7
Lappeenranta 7
Lima 7
Ningbo 7
Redwood City 7
Salvador 7
Taiyuan 7
Thái Bình 7
Tokyo 7
Biên Hòa 6
Blumenau 6
Bogotá 6
Brooklyn 6
Cabo Frio 6
Caxias do Sul 6
Chengdu 6
Chennai 6
Guayaquil 6
Totale 11.249
Salva come PNG Salva come JPEG
Nome #
ONCOLOGIA MEDICA 197
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 197
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 196
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 191
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 183
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 168
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 165
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 165
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 164
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 163
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 161
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 158
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 157
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 157
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 157
Clinical management of advanced gastric cancer: Role of new molecular drugs. 156
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 156
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 156
Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer 154
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 154
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 154
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 150
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 150
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 149
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 148
Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors 148
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 147
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 146
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 146
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case Series 144
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 144
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 142
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 142
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 142
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 141
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 140
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 139
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 138
Treatment of gastric cancer. 136
Adult Wilms' tumor: a case report 136
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 135
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 132
Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery 132
Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations 132
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 131
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 130
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 130
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 129
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 128
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 128
Farmacogenomica e cancro colorettale 127
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 126
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 125
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 125
Cardiotossicità da antracicline: attualità e prospettive 125
TRASTUZUMAB RESISTANCE IN BREAST CANCER 125
Post-Irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review 124
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 123
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 123
Adjuvant chemotherapy of gastric cancer: which regimen? 122
Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review 121
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 120
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 120
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 119
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 118
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 118
Chemoradiotherapy as adjuvant treatment of gastric cancer 117
Targeting EGFR in Pancreatic Cancer Treatment. 117
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 116
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 116
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 116
ENDOSONOGRAPHIC ASSESSMENT OF RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PREDICTING SURVIVAL OF ESOPHAGEAL CARCINOMA PATIENTS 116
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 116
Integrated therapy in localized gastric cancer: targeted and tailored approach. 115
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 115
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 115
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 115
Ventricular repolarization time indexes following anthracycline treatment 115
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 115
Propensity score-matched comparison between complete mesocolic excision and classic right hemicolectomy for colon cancer 115
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 115
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 114
A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patients. 114
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 113
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 113
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 113
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery 112
Il linfoma primitivo della parotide: una localizzazione infrequente 112
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study 111
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 111
Preoperative chemo-radiotherapy for carcinoma of the esophagus 110
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next generation sequencing: findings from the CAPRI-GOIM trial. 110
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 110
First line chemotherapy versus bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases 109
Impact of total fundoplication on esophageal transit: analysis by combined multichannel intraluminal impedance and manometry. 109
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation 108
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 108
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients 108
Hypercoagulable state in patients with advanced gastrointestinal cancer: evidence for an acquired resistance to activated protein C 107
Neo-adjuvant and adjuvant chemotherapy of gastric cancer 107
Totale 13.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021738 0 0 0 0 0 16 193 141 13 165 144 66
2021/20221.150 99 3 17 19 407 6 19 37 41 53 114 335
2022/20232.666 319 45 37 206 304 205 15 158 1.281 11 44 41
2023/2024993 84 31 48 85 347 127 9 21 8 18 64 151
2024/20253.006 22 92 40 76 476 383 396 275 414 346 233 253
2025/202610.756 484 606 636 678 1.036 7.316 0 0 0 0 0 0
Totale 22.753